MedTrace Logo

NSCLC Burden of Illness Study

NCT01772225 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2014-03-31

No results posted yet for this study

Summary

The aim of this observational study is to identify and quantify the humanistic and economic burden of illness of patients with complete resection (no residual disease) of stage IB-IIIA NSCLC in three European countries (France, Germany, and the United Kingdom \[UK\]). Data collection will be conducted through patient medical record abstraction and patient survey.

Conditions

  • Lung Cancer, Non-Small Cell

Interventions

OTHER

Data collection

Medical record abstraction form and patient survey questionnaire.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-01-31
Completion
2014-01-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01772225 on ClinicalTrials.gov